Filtered By:
Source: Clinical and Applied Thrombosis/Hemostasis
Condition: Thrombosis
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 33 results found since Jan 2013.
Red Cell Distribution Width Is Related to Stroke in Patients With Heart Failure
Source: Clinical and Applied Thrombosis/Hemostasis - February 2, 2015 Category: Hematology Authors: Balta, S., Demir, M., Demirkol, S., Arslan, Z., Unlu, M., Celik, T. Tags: Letter to the Editor Source Type: research
Baseline SYNTAX Score and Long-Term Outcome in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Conclusion:
The SXscore is an independent predictor of both in-hospital and long-term mortality and MACE in patients with acute STEMI undergoing primary PCI.
Source: Clinical and Applied Thrombosis/Hemostasis - October 5, 2015 Category: Hematology Authors: Akgun, T., Oduncu, V., Bitigen, A., Karabay, C. Y., Erkol, A., Kocabay, G., Ozveren, O., Yildiz, A., Cimen, A. O., Kirma, C. Tags: Original Articles Source Type: research
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications
Conclusion:
The evidence for each dosing regimen demonstrates that although pharmacology studies are of paramount importance, dose regimens must be subjected to careful empirical validation. Once-daily dosing was shown to be clinically appropriate for most rivaroxaban indications. Furthermore, a "one size fits all" approach to dosing frequency is unlikely to result in a regimen that yields optimal patient outcomes across different indications.
Source: Clinical and Applied Thrombosis/Hemostasis - May 28, 2016 Category: Hematology Authors: Kubitza, D., Berkowitz, S. D., Misselwitz, F. Tags: Reviews Source Type: research
